Filing Details
- Accession Number:
- 0001104659-23-052984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-28 16:15:55
- Reporting Period:
- 2023-04-26
- Accepted Time:
- 2023-04-28 16:15:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1442836 | Mersana Therapeutics Inc. | MRSN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645755 | Alejandra Carvajal | C/O Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139 | Svp, Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-26 | 13,250 | $0.00 | 24,270 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-27 | 3,944 | $3.89 | 20,326 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted stock unit | Disposition | 2023-04-26 | 13,250 | $0.00 | 13,250 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon the vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on April 26, 2021.
- Pursuant to automatic sell-to-cover instructions adopted by the Reporting Person on April 26, 2021, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The automatic sale instructions for the sell-to-cover were intended to comply with the requirements of Rule 10b5-1(c). The sale was not a discretionary trade by the Reporting Person.
- Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- The RSUs vested as to 50% of the shares on April 26, 2022 and as to 50% of the shares on April 26, 2023.
Billionaire Hedge Funds
